Jeffrey W. Albers, Director at Blueprint Medicines Corp (BPMC), sold 5,650 shares at $101.02 ($572K) on 2025-05-27, disclosed to the SEC on 2025-05-29.
Scheduled sale ($572k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.02 | 4,350 | $439K | 76.8% |
| 2 | $101.93 | 650 | $66K | 11.6% |
| 3 | $101.93 | 650 | $66K | 11.6% |
| Total | $101.23 avg | 5,650 | $572K | 100% |
| Filing → |
| KYMR | SELL | 2025-10-14 | $296K | — | Filing → |
| KYMR | SELL | 2025-06-03 | $311K | — | Filing → |
| BPMC | SELL | 2025-03-17 | $1.0M | — | Filing → |